[vc_row css=”.vc_custom_1517939115140{padding-right: 20px !important;padding-left: 20px !important;background-color: #fbfbfb !important;}”][vc_column][vc_column_text]Published on May 21, 2020
Dr. Ramsin Benyamin discusses differential target multiplexed spinal cord stimulation (DTM-SCS) for chronic back pain. He starts with a comparison of neuronal and glial cell prevalence in the spinal cord before turning to the theory of targeted, multiplexed SCS and the value of glial targeting. Dr. Benyamin provides data from a prospective study demonstrating that DTM-SCS is significantly more effective in treating back and leg pain compared to standard SCS.
[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text css=”.vc_custom_1488298613118{margin-top: -20px !important;}”]
[/vc_column_text][/vc_column][/vc_row]